Diagonal Bio AB (publ) (NGM:DIABIO)
0.0040
0.00 (0.00%)
At close: Dec 3, 2025
Diagonal Bio AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 1.74 | 0.82 | 2.97 | 13.59 | 20.77 | 3.67 |
| Cash & Short-Term Investments | 1.74 | 0.82 | 2.97 | 13.59 | 20.77 | 3.67 |
| Cash Growth | 0.40% | -72.48% | -78.12% | -34.58% | 466.14% | - |
| Accounts Receivable | 0.05 | - | 0.02 | - | 0.19 | - |
| Other Receivables | 0.25 | 0.2 | 0.5 | 0.68 | 0.28 | 0.3 |
| Receivables | 0.3 | 0.2 | 0.52 | 0.68 | 0.47 | 0.3 |
| Inventory | 1.58 | 0.55 | 1.03 | - | - | - |
| Prepaid Expenses | 0.22 | 0.2 | 0.21 | 0.23 | 0.21 | 0.03 |
| Other Current Assets | 0.53 | 0.83 | - | - | - | - |
| Total Current Assets | 4.37 | 2.6 | 4.73 | 14.5 | 21.44 | 3.99 |
| Property, Plant & Equipment | 0.01 | 0.01 | 0.02 | - | - | - |
| Other Intangible Assets | 3.61 | 3.4 | 2.88 | 1.78 | 0.33 | - |
| Long-Term Deferred Charges | 21.12 | 21.12 | 20.87 | 17.74 | 14.24 | 5.98 |
| Total Assets | 29.1 | 27.13 | 28.51 | 34.03 | 36.01 | 9.97 |
| Accounts Payable | 0.33 | 0.44 | 1.91 | 1.61 | 0.58 | 0.96 |
| Accrued Expenses | 0.6 | 0.4 | 1 | 0.83 | 0.78 | 0.08 |
| Current Unearned Revenue | - | - | - | - | 0.2 | - |
| Other Current Liabilities | 1.2 | 1.7 | 4.35 | 0.34 | 0.58 | 0.04 |
| Total Current Liabilities | 2.13 | 2.54 | 7.26 | 2.78 | 2.14 | 1.08 |
| Other Long-Term Liabilities | 0 | - | 0 | -0 | - | - |
| Total Liabilities | 2.13 | 2.54 | 7.26 | 2.78 | 2.14 | 1.08 |
| Common Stock | 5.61 | 4 | 4 | 3.48 | 0.92 | 0.03 |
| Additional Paid-In Capital | 52.78 | 52.49 | 57.25 | 56.18 | 45.2 | 9.44 |
| Retained Earnings | -31.42 | -31.9 | -40 | -28.41 | -12.25 | -0.58 |
| Comprehensive Income & Other | - | 0 | - | - | - | 0.01 |
| Shareholders' Equity | 26.97 | 24.6 | 21.25 | 31.25 | 33.87 | 8.89 |
| Total Liabilities & Equity | 29.1 | 27.13 | 28.51 | 34.03 | 36.01 | 9.97 |
| Net Cash (Debt) | 1.74 | 0.82 | 2.97 | 13.59 | 20.77 | 3.67 |
| Net Cash Growth | 0.40% | -72.48% | -78.12% | -34.58% | 466.14% | - |
| Net Cash Per Share | 0.00 | 0.00 | 0.08 | 1.43 | 3.02 | 1.05 |
| Filing Date Shares Outstanding | 1,634 | 1,215 | 39.98 | 34.77 | 9.15 | 2.15 |
| Total Common Shares Outstanding | 1,634 | 400.71 | 39.98 | 34.77 | 9.15 | 2.15 |
| Working Capital | 2.24 | 0.07 | -2.53 | 11.72 | 19.29 | 2.92 |
| Book Value Per Share | 0.02 | 0.06 | 0.53 | 0.90 | 3.70 | 4.14 |
| Tangible Book Value | 23.36 | 21.2 | 18.37 | 29.47 | 33.53 | 8.89 |
| Tangible Book Value Per Share | 0.01 | 0.05 | 0.46 | 0.85 | 3.67 | 4.14 |
| Machinery | - | 0.02 | 0.02 | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.